For citations:
Arevefa A.N., Dorotenko A.R., Noskov S.M., Makarenko I.E., Drai R.V., Komarov T.N., Archakova O.A., Bagaeva N.S., Shokhin I.E. An Open-label Randomized Crossover Study with Adaptive Design of the Pharmacokinetics and Bioequivalence of GP30121 and Ceraxon® Corrected for Endogenous Analyte Level. Drug development & registration. 2023;12(3):218-227. https://doi.org/10.33380/2305-2066-2023-12-3-218-227
Views PDF (Eng): 32
Email this article 